Roche finally dumps phase 3 prostate cancer prospect
03 Feb 2023 //
FIERCE BIOTECH
Roche scraps 5 trials while Alzheimer`s, TIGIT plans still risky
21 Jul 2022 //
FIERCEBIOTECH
Roche chucks out phase 3 ipatasertib combo tests
04 Feb 2021 //
FIERCE BIOTECH
ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga
21 Sep 2020 //
FIERCE BIOTECH
SU2C to support clinical trials in breast and prostate cancers
18 Sep 2019 //
CLINEICALTRIALSARENA
Roche’s ipatasertib combo shows early promise in triple-negative breast cancer
03 Apr 2019 //
PHARMA TIMES
Tecentriq combo shows promise in triple negative breast cancer
01 Apr 2019 //
PMLIVE